Lotte Biologics Seoul, Korea (the Democratic People's Republic of)

About Lotte Biologics:

LOTTE BIOLOGICS was established in 2022, and is headquartered in Seoul, South Korea. The company will operate as a biological CDMO that provides a high level of manufacturing services from clinical to commercial products.
LOTTE BIOLOGICS will be entering the biologics CDMO business after acquiring Bristol Myers Squibb’s Syracuse biologics drug substance manufacturing site, which is expected to be completed in 2022.
The newly established organization aims to become a Global Top 10 CDMO company...ny in the biopharmaceutical industry.

With initial operations in 1948 in Japan, LOTTE has grown to become the fifth-largest conglomerate corporation in South Korea.
LOTTE has various business units, including petro/fine chemicals, food, retail, hotels, electronics, construction, and IT.
LOTTE has 30+ global locations across the US, Europe, and Asia. read more

Service Offerings:

• Biological Drug substance manufacturing
• Cell Banking & inoculum
• Cell Culture
• Harvest
• Downstream process
• Cryogenic storage of drug substance
• Process development
• Analytical testing services
• Quality control

Reviews: